Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Second-generation interferons for cancer: clinical targets.

E C Borden1, D Lindner, R Dreicer

  • 1Taussig Cancer Center, Learner Research Institute, Cleveland, OH 44195, USA. bordene@cc.ccf.org

Seminars in Cancer Biology
|August 11, 2000
PubMed
Summary

Interferons (IFNs) are pioneering cancer therapies. Further research into IFN diversity and action mechanisms will unlock new treatments for various cancers, including leukemia and melanoma.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interferon Alfa-2b Adjuvant Therapy of High-Risk Resected Cutaneous Melanoma: The Eastern Cooperative Oncology Group Trial EST 1684.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023
Same author

Informing the delivery of cancer survivorship care in rural primary care practice.

Journal of cancer survivorship : research and practice·2022
Same author

Consensus statement from the international consensus meeting on post-traumatic cranioplasty.

Acta neurochirurgica·2020
Same author

Dynamic infrared thermography (DIRT) for assessment of skin blood perfusion in cranioplasty: a proof of concept for qualitative comparison with the standard indocyanine green video angiography (ICGA).

International journal of computer assisted radiology and surgery·2017
Same author

Identification of Ezrin-Radixin-Moesin proteins as novel regulators of pathogenic B-cell receptor signaling and tumor growth in diffuse large B-cell lymphoma.

Leukemia·2015
Same author

[Deep brain stimulation using simultaneous stereotactic electrode placement: an alternative to conventional functional stereotaxy?].

Der Nervenarzt·2014

Area of Science:

  • Biochemistry
  • Immunology
  • Oncology

Background:

  • Interferons (IFNs) represent a breakthrough in recombinant DNA technology and were the first human proteins successfully used in cancer therapy.
  • Despite their success, significant research is needed to fully understand the IFN system and expand its clinical applications.

Purpose of the Study:

  • To review the diversity of the Interferon (IFN) family.
  • To explore chemical modifications leading to second-generation IFNs.
  • To highlight new therapeutic directions for IFNs in various cancers based on pre-clinical and clinical findings.

Main Methods:

  • Literature review focusing on IFN family diversity.
  • Analysis of chemical modifications for developing advanced IFNs.
  • Synthesis of pre-clinical and clinical data for therapeutic applications.

Related Experiment Videos

Main Results:

  • The review emphasizes the broad diversity within the IFN family.
  • Chemical modifications are crucial for creating next-generation IFNs with improved efficacy.
  • IFNs show promise for treating chronic myelogenous leukemia, lymphomas, myelomas, melanoma, urologic malignancies, primary brain tumors, and ovarian carcinoma.

Conclusions:

  • Understanding IFN diversity and action is key to unlocking new therapeutic potential.
  • Second-generation IFNs developed through chemical modifications offer enhanced treatment options.
  • IFNs are valuable in treating a wide range of hematologic and solid tumors.